|
Migraine is a chronic, debilitating disorder that affects approximately 28 million Americans of whom ~18% are women and ~6% are men. Recent epidemiologic data have shown that although there has been a slow increase in the diagnosis and treatment rates of migraine, it continues to remain undertreated. The prevalence of migraine increases in women during their menstrual cycle, commonly referred to as menstrual migraine (MM). When compared to migraines that occur during other times of the month, MM may last longer and be more severe, disabling, frequent, and more difficult to treat. By understanding the pathophysiology of MM, the role of hormones in migraine, and utilizing diagnostic tools and questionnaires, clinicians can effectively diagnose and implement prompt and appropriate treatment. Additionally, by evaluating characteristics of the patient, and her migraine, and match treatment approaches accordingly, clinicians will improve treatment outcomes among their patients with MM and ultimately improve patient quality of life and decrease associated disability. This program will address the new advances in the understanding of MM, the role of hormones, and how to select an appropriate treatment based on individual patient characteristics.
Learning Objectives
After completing this activity, the participant will be able to:
- Recognize migraine in the differential diagnosis of headaches that impact patients ability to fully function in their daily activities and identify menstrual migraine in female patients
- Identify management strategies for women with menstrual migraine including use of headache calendars, behavioral modifications and approaches to acute and preventive treatment
Release date: February 23, 2009
Expiration date: February 23, 2010
Medium: Podcast
Acknowledgement of Commercial Support:
This activity was developed from the live Best Practices in Primary Care™ program held in Seattle, Washington on March 15, 2008 which was funded by Endo Pharmaceuticals Inc.
Method of Participation:
To receive CME credit for this activity, you need to listen to the program. Upon finishing the podcast, complete the post-test and evaluation, and fill out all required personal information. To receive your CME certificate you will need to pass the post-test with 70% accuracy or better.
Post-test and Evaluation:
After completing this activity, click on the Post-test button at the end of the program. If you receive less than 70% on the post-test, you will be returned to the beginning of the activity to review the presentation again. Upon successful completion of the post-test, you will be asked to fill out a program evaluation form and prompted to print your CME certificate.
Statement of Disclosure and Independence:
It is the policy of Primary Care Network, Inc. to ensure all its sponsored educational activities are planned, developed, and conducted in accordance with the ACCME’s Essential Areas and Policies. In accordance with ACCME requirements, Primary Care Network has Conflict of Interest and Disclosure Policies that are designed to ensure that Primary Care Network sponsored educational activities are fair balanced, independent, evidence-based and based on scientific rigor.
Primary Care Network’s Resolution of Personal Conflicts of Interest (COI) Policy aims to ensure that all conflicts are resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a Primary Care Network sponsored activity are required to disclose to the participants any real or apparent conflict of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent external clinical reviewer and internal clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.
The opinions, ideas, recommendations, and perspectives expressed in the accompanying presentations at this Primary Care Education program are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, Primary Care Education, Advisory Boards and Consultants, or the activity’s commercial supporters.
Planning Committee and Disclosures
Brian Koffman, MD
Clinical Professor, Department of Family Medicine
Keck School of Medicine, USC Family Practice
St. Jude Heritage Healthcare
Diamond Bar, CA
Dr. Koffman is a member of the speaker’s bureau for Pfizer, Inc.
Lisa K. Mannix, MD
Medical Director
Headache Associates
Cincinnati, OH
Dr. Mannix is a member of the speaker’s bureau for Endo Pharmaceuticals Inc., GlaxoSmithKline, Merck & Co., Inc., and Ortho-McNeil. She serves on the advisory board for Allergan, Inc., Endo, GlaxoSmithKline, MAP Pharmaceuticals, Inc., Merck, and Ortho-McNeil. Dr. Mannix is a consultant to Allergan, Endo, GlaxoSmithKline, MAP, Merck, and Ortho-McNeil. She also receives research grant support from Alexza Pharmaceuticals, Allergan, Endo, GlaxoSmithKline, MAP, Merck, Ortho-McNeil, Pozen Pharmaceuticals, and TorreyPines Institute.
Vincent Martin, MD
Professor of Clinical Medicine
University of Cincinnati
Cincinnati, OH
Dr. Martin is a member of the speaker’s bureau for Endo Pharmaceuticals Inc. and Merck & Co., Inc. He serves on the advisory board for Endo, GlaxoSmithKline, and Merck. Dr. Martin is a consultant to Allergan, Inc., Fision Pharmaceutical, and GlaxoSmithKline. He receives research grant funding from Endo and GlaxoSmithKline and is also a stock shareholder of Johnson & Johnson.
Faculty and Disclosures
Brian Koffman, MD
Clinical Professor, Department of Family Medicine
Keck School of Medicine, USC Family Practice
St. Jude Heritage Healthcare
Diamond Bar, CA
Dr. Koffman is a member of the speaker’s bureau for Pfizer, Inc.
Steven B. Graff-Radford, DDS
Director, Program for Headache and Orofacial Pain
The Pain Center, Cedars-Sinai Medical Center
Los Angeles, CA
Dr. Graff-Radford is a member of the speaker’s bureau for Allergan, Inc., AstraZeneca, Endo Pharmaceuticals Inc., GlaxoSmithKline, Merck & Co., Ortho-McNeil, Pfizer, Inc., and Pharmacia. He serves on the advisory board for Endo, GlaxoSmithKline, Merck, and Ortho-McNeil and is a consultant to GlaxoSmithKline and Merck.
Review Committee Disclosure
In accordance with our policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers, staff, and other individuals who control content have no relevant financial relationships to disclose.
Unlabeled Use Declaration:
During their presentation(s), faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.
 Listen to Podcast
When finished, click here to take the Post-test
Take the post-test to receive your CME certificate
|
